FAKTOR-OPTIONSSCHEIN - PFIZER INC | Real-time Boerse Frankfurt Warrants 11:08:27 10/06/2024 BST | ||
| 2.1 EUR | -0.47% |
|
| Current month | +1.44% | ||
| 1 month | +7.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 10/06/24 | 2.1 | -0.47% |
| 07/06/24 | 2.11 | -1.86% |
| 06/06/24 | 2.15 | -6.52% |
| 05/06/24 | 2.3 | +1.32% |
| 04/06/24 | 2.27 | +1.79% |
Real-time Boerse Frankfurt Warrants
Last update June 10, 2024 at 11:08 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| WKN | SB01H3 |
| ISIN | DE000SB01H33 |
| Date issued | 09/06/2020 |
| Strike | 35.95 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 36.93 € |
|---|---|
| Lowest since issue | 1.51 € |
| Spread | 0.02 € |
| Spread % | 0.94% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.58
USD
Average target price
31.92
USD
Spread / Average Target
+11.67%
- Stock Market
- Certificates
- Certificat
